<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">F1000Res</journal-id><journal-id journal-id-type="iso-abbrev">F1000Res</journal-id><journal-id journal-id-type="pmc">F1000Research</journal-id><journal-title-group><journal-title>F1000Research</journal-title></journal-title-group><issn pub-type="epub">2046-1402</issn><publisher><publisher-name>F1000Research</publisher-name><publisher-loc>London, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27429745</article-id><article-id pub-id-type="pmc">4943294</article-id><article-id pub-id-type="doi">10.12688/f1000research.8993.1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group><subject>Articles</subject><subj-group><subject>Hemodynamics, Vasc. Biology &#x00026; Hypertension Sec. to Kidney Dis.</subject></subj-group><subj-group><subject>Stones &#x00026; Endourology</subject></subj-group></subj-group></article-categories><title-group><article-title>Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones: a prospective study</article-title><fn-group content-type="pub-status"><fn><p>[version 1; referees: 1 approved</p></fn></fn-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Syahputra</surname><given-names>Firtantyo Adi</given-names></name><xref ref-type="corresp" rid="c1">a</xref><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Birowo</surname><given-names>Ponco</given-names></name><xref ref-type="corresp" rid="c2">b</xref><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rasyid</surname><given-names>Nur</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Matondang</surname><given-names>Faisal Abdi</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Noviandrini</surname><given-names>Endrika</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Huseini</surname><given-names>Maruto Harjanggi</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><aff id="a1">
<label>1</label>Department of Urology, Cipto Mangunkusumo Hospital / Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia</aff></contrib-group><author-notes><corresp id="c1"><label>a</label><email xlink:href="mailto:dokter.tio@gmail.com">dokter.tio@gmail.com</email></corresp><corresp id="c2"><label>b</label><email xlink:href="mailto:ponco.birowo@gmail.com">ponco.birowo@gmail.com</email></corresp><fn fn-type="con"><p>FAS - study concepts, design of study, data acquisition, data interpretation, statistical analysis, manuscript preparation. PB - study concepts, design of study, manuscript review, funds collection. NR - design of study, manuscript review, funds collection. FAM - literature research, data acquisition. EN - manuscript editing. MHH - manuscript editing. All authors have agreed to publish this final manuscript.</p></fn><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><elocation-id>1550</elocation-id><history><date date-type="accepted"><day>28</day><month>6</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2016 Syahputra FA et al.</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="f1000research-5-9674.pdf"/><abstract><p>
<bold>Objectives</bold>
</p><p> Bleeding is the most common complication of percutaneous nephrolithotomy (PCNL). Injudicious transfusion is frequently performed in current practice, even though it is not always needed. This study aimed to identify the predictive factors of blood loss in the PCNL procedure and evaluate the perioperative transfusion practice.</p><p>
<bold>Methods</bold>
</p><p> A prospective study of PCNL was randomly performed by two consultants of endo-urology at our institution. The inclusion criteria were adults with kidney pelvic stones &#x0003e;20 mm or stone in inferior calyx &#x0003e;10 mm or staghorn stone. Those with coagulopathy, under anti-coagulant treatment or open conversion were excluded. A full blood count was taken at baseline and during 12, 24, 36, 72-hours post-operatively. Factors such as stone burden, sex, body surface area, shifting of hematocrit level and amount of blood transfused were analyzed statistically using line regression to identify the predictive factors of total blood loss (TBL).</p><p>
<bold>&#x000a0;</bold>
</p><p>
<bold> Results</bold>
</p><p> Eighty-five patients were enrolled in this study. Mean TBL was 560.92 &#x000b1; 428.43 mL for both endo-urology surgeons. Stone burden was the most influential factor for TBL (p=0.037). Our results revealed that TBL (mL) = -153.379 + 0.229 &#x000d7; stone burden (mm2) + 0.203 x baseline serum hematocrit (%); thus considerably predicted the need for blood transfusion. A total of 87.1% patients did not receive perioperative transfusion, 3.5% received intra-operative transfusion, 7.1% received post-operative transfusion, 23% had both intra and post-operative transfusion, resulting in a cross-matched transfusion ratio of 7.72. Mean perioperative blood transfused was 356.00 &#x000b1; 145.88 mL.</p></abstract><kwd-group kwd-group-type="author"><kwd>Bleeding</kwd><kwd>nephrolithiasis</kwd><kwd>PCNL</kwd><kwd>transfusion</kwd></kwd-group><funding-group><funding-statement>Cipto Mangunkusumo Hospital Operational Research Grant 2013 funded this research.</funding-statement><funding-statement><italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic></funding-statement></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Kidney stones prove to be a common affliction in many countries worldwide because of high incidence and prevalence. In America, kidney stone incidence was found in 116 out of 100,000 individuals
<sup><xref rid="ref-1" ref-type="bibr">1</xref></sup>. A higher incidence was discovered in the German population aged 14 years and older, amounting to 720 out of 100,000 individuals
<sup><xref rid="ref-2" ref-type="bibr">2</xref></sup>. An excessively high number of cases was found in Asian countries, namely, 114.3 per 100,000 in Japan, while Iranian urolithiasis incidence was assessed at 145.1 in 2005
<sup><xref rid="ref-3" ref-type="bibr">3</xref></sup>. A global increase in kidney stone cases was determined in individuals of all ages, sex, and races
<sup><xref rid="ref-4" ref-type="bibr">4</xref></sup>. In our institution we have, to date, treated an increasing number of kidney stone patients, from 182 in 1997 to 847 in 2002
<sup><xref rid="ref-5" ref-type="bibr">5</xref></sup>.
</p><p>Percutaneous nephrolithotomy (PCNL) is a urological minimally-invasive procedure to extract kidney stones by means of percutaneous access
<sup><xref rid="ref-6" ref-type="bibr">6</xref></sup>. Nowadays, PCNL is widely accepted to treat those complex kidney stone cases that are hard in consistency, of a large size, infected, obstructed with anatomical abnormalities, generally cases that could not be treated by other modalities
<sup><xref rid="ref-7" ref-type="bibr">7</xref></sup>. In European guidelines, PCNL is favoured as the treatment of choice for calyx and pelvic stones &#x0003e;20 mm
<sup>2</sup>
<sup><xref rid="ref-8" ref-type="bibr">8</xref></sup>. For stones &#x0003e;20 mm, PCNL demonstrated a stone-free rate up to 78&#x02013;95%
<sup><xref rid="ref-9" ref-type="bibr">9</xref></sup>. There has been a decrease in open surgery number in our institution during 2001&#x02013;2009, whereby the PCNL procedure has become more frequent
<sup><xref rid="ref-10" ref-type="bibr">10</xref></sup>.
</p><p>One of the most bothersome complications of PCNL is hemorrhage. Direct access to the pelvicalyceal system and intrarenal manipulation during PCNL procedures cause injury to the renal vasculature, particularly to the segmental and interlobar arteries. The renal-collecting system is rich in vascularization, covering 20% of the total cardiac output, and often results in hemorrhage during PCNL
<sup><xref rid="ref-11" ref-type="bibr">11</xref></sup>. The high percentage of blood loss and the necessity of transfusion often results in the erroneous management of hemorrhage during the PCNL procedure.</p><p>It has been reported that 1&#x02013;11% of patients who underwent PCNL required blood transfusion; a higher transfusion rate, 2&#x02013;53% was determined in the staghorn cases
<sup><xref rid="ref-11" ref-type="bibr">11</xref></sup>. Previous studies describe many hemorrhage risk factors during PCNL, such as, age
<sup><xref rid="ref-12" ref-type="bibr">12</xref></sup>, pre-operative urinary tract infections
<sup><xref rid="ref-12" ref-type="bibr">12</xref></sup>, large stones (exceeding 1250 mm
<sup>2</sup>)
<sup><xref rid="ref-13" ref-type="bibr">13</xref></sup>, staghorn calculi
<sup><xref rid="ref-13" ref-type="bibr">13</xref>,
<xref rid="ref-14" ref-type="bibr">14</xref></sup>, multiple access
<sup><xref rid="ref-11" ref-type="bibr">11</xref>,
<xref rid="ref-13" ref-type="bibr">13</xref>,
<xref rid="ref-14" ref-type="bibr">14</xref></sup>, diabetes mellitus
<sup><xref rid="ref-11" ref-type="bibr">11</xref>,
<xref rid="ref-13" ref-type="bibr">13</xref>,
<xref rid="ref-15" ref-type="bibr">15</xref></sup>, prolonged surgery time
<sup><xref rid="ref-11" ref-type="bibr">11</xref>&#x02013;
<xref rid="ref-13" ref-type="bibr">13</xref></sup> and stone composition
<sup><xref rid="ref-13" ref-type="bibr">13</xref></sup>. Other risk factors have been postulated: i.e. stone location, pre-operative hemoglobin, hydronephrosis grade, renal parenchymal thickness, however, to date, have not yet been proven. Many of the hemorrhage cases during PCNL could be managed conservatively, however, 0.8% patients required a more invasive procedure to deal with the bleeding
<sup><xref rid="ref-14" ref-type="bibr">14</xref></sup>.
</p><p>To date there are no specific data available to determine the blood transfusion requirement during PCNL procedures. In our institution, blood units are requested pre-operatively according to clinical estimation. However, this does not always concede to the intra-operative blood loss. This study was aimed at predicting the amount of blood loss during PCNL by identifying the pre-operative factors that could possibly lead to a lower morbidity rate.</p></sec><sec sec-type="materials | methods"><title>Materials and methods</title><p>The present study includes patients who underwent percutaneous nephrolithotomy procedure in our hospital from October 2012 to October 2013. Adult patients (&#x02265;18 years old) with pelvic stones &#x0003e;20 mm, inferior calyx stones &#x0003e;10 mm or staghorn stones who agreed to enroll by written informed consent were included in this study. Those with coagulopathy, under anti-coagulant treatment or conversion to open procedure were excluded.</p><p>Patients were admitted the day prior to procedure. Stone burden was assessed pre-operatively by multiplying sum of length and width by means of imaging. The PCNL was randomly performed under spinal anesthesia by two endo-urology consultants. The patient was placed in prone position, access gained to pelvicalyceal system with fluoroscopic guidance, followed by dilatation using a metal and fascia dilator before application of sheath. The number and location of punctures were decided intra-operatively, based on pelvicalyceal system. We used pneumatic lithotripsy to break the stone which was subsequently extracted by forceps or grasper. The procedure was completed when the patient was stone-free and any arising complications alleviated.</p><p>Full blood counts were taken prior to procedure and thereafter at 12, 24, 36, 72-hours post-operatively. Total blood loss was calculated considering body surface area, sex-adjusted estimated blood volume, initial hematocrit level and 72-hour post-operative hematocrit level. Study protocol has been approved by the Ethical Committee, Faculty of Medicine, Universitas Indonesia (No.89/H2.F1/ETIK/2013).</p><p>We compiled a chart
<sup><xref rid="ref-15" ref-type="bibr">15</xref>,
<xref rid="ref-16" ref-type="bibr">16</xref></sup> to assess total blood loss (TBL) to include sex, body surface area, shifting of hematocrit level and amount of blood transfused, as shown in
<xref ref-type="table" rid="T1">Table 1</xref>.</p><table-wrap id="T1" orientation="portrait" position="anchor"><label>Table 1. </label><caption><title>Operational definition.</title></caption><table frame="hsides" rules="groups" content-type="article-table"><thead><tr><th align="center" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Formula</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Body Surface Area (m
<sup>2</sup>)
<sup><xref rid="ref-15" ref-type="bibr">15</xref></sup>
</td><td align="center" rowspan="1" colspan="1">0.0235 &#x000d7; [Height (cm)]
<sup>0.42246</sup> &#x000d7; [BW (kg)]
<sup>0.51456</sup>
</td></tr><tr><td align="center" rowspan="2" colspan="1">Estimated Blood Volume (mL)
<sup><xref rid="ref-15" ref-type="bibr">15</xref></sup>
</td><td align="center" rowspan="1" colspan="1">Female: [Body Surface Area (m
<sup>2</sup>)] &#x000d7; 2430</td></tr><tr><td align="center" rowspan="1" colspan="1">Male: [Body Surface Area (m
<sup>2</sup>)] &#x000d7; 2530</td></tr><tr><td align="center" rowspan="1" colspan="1">Initial RBC (mL)
<sup><xref rid="ref-15" ref-type="bibr">15</xref></sup>
</td><td align="center" rowspan="1" colspan="1">[Estimated Blood Volume (mL)] &#x000d7; [Initial Hematocrit level 24-hour pre-op (%)]</td></tr><tr><td align="center" rowspan="1" colspan="1">Final RBC (mL)
<sup><xref rid="ref-15" ref-type="bibr">15</xref></sup>
</td><td align="center" rowspan="1" colspan="1">[Estimated Blood Volume (mL)] &#x000d7;[Final Hematocrit level 72-hour post-op (%)]</td></tr><tr><td align="center" rowspan="1" colspan="1">Uncompensated RBC Loss (mL)
<sup><xref rid="ref-15" ref-type="bibr">15</xref></sup>
</td><td align="center" rowspan="1" colspan="1">[Initial RBC (mL)] &#x02013; [Final RBC (mL)]</td></tr><tr><td align="center" rowspan="1" colspan="1">Compensated RBC Loss (mL)
<sup><xref rid="ref-15" ref-type="bibr">15</xref></sup>
</td><td align="center" rowspan="1" colspan="1">[Amount of RBC transfused from intra-op to 72-hour post-op]</td></tr><tr><td align="center" rowspan="1" colspan="1">Total RBC Loss (mL)
<sup><xref rid="ref-15" ref-type="bibr">15</xref></sup>
</td><td align="center" rowspan="1" colspan="1">[Uncompensated RBC Loss (mL)] + [Compensated RBC Loss (mL)]</td></tr><tr><td align="center" rowspan="1" colspan="1">Total Blood Loss (mL)
<sup><xref rid="ref-16" ref-type="bibr">16</xref></sup>
</td><td align="center" rowspan="1" colspan="1">
<inline-formula><mml:math id="math1"><mml:mrow><mml:mfrac><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mtext>Total</mml:mtext><mml:mspace width="0.2em"/><mml:mtext>RBC</mml:mtext><mml:mspace width="0.2em"/><mml:mtext>Loss</mml:mtext><mml:mspace width="0.2em"/><mml:mo stretchy="false">(</mml:mo><mml:mtext>mL</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mtext>Hematocrit</mml:mtext><mml:mspace width="0.2em"/><mml:mn>24-</mml:mn><mml:mtext>hour</mml:mtext><mml:mspace width="0.2em"/><mml:mtext>pre-op</mml:mtext><mml:mo>+</mml:mo><mml:mtext>Hematocrit</mml:mtext><mml:mspace width="0.2em"/><mml:mn>72-</mml:mn><mml:mtext>hour</mml:mtext><mml:mspace width="0.2em"/><mml:mtext>post-op</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Cross match transfusion ratio/CT
<break/>ratio
<sup><xref rid="ref-17" ref-type="bibr">17</xref></sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Amount of blood unit cross-matched : Amount of blood unit transfused</td></tr><tr><td align="center" rowspan="1" colspan="1">Under-transfusion
<sup><xref rid="ref-18" ref-type="bibr">18</xref></sup>
</td><td align="center" rowspan="1" colspan="1">Defined as blood volume transfused deficit less than 15.0% of total blood loss (mL)</td></tr><tr><td align="center" rowspan="1" colspan="1">Over-transfusion
<sup><xref rid="ref-18" ref-type="bibr">18</xref></sup>
</td><td align="center" rowspan="1" colspan="1">Defined as blood volume transfused excess greater than 15.0% of total blood loss (mL)</td></tr></tbody></table><table-wrap-foot><fn id="fn1"><p>
<bold>Abbreviations:</bold> RBC = red blood cell, BW = body weight</p></fn></table-wrap-foot></table-wrap><p>Bivariate analysis was done by correlating numerical variables with total blood loss, and associating categorical variables with perioperative blood transfusion amount. Those with significancy of &#x0003c;0.25 were further analyzed with multivariate analysis of linier and logistic regression.</p></sec><sec sec-type="results"><title>Results</title><p>A total of 85 PCNL procedures were performed on 85 patients (46 males, 39 females) who completed this study, thus gave statistical power of 0.8. The average age was 50.96 &#x000b1; 11.87 years. Most of the patients complained of flank pain at initial presentation (
<xref ref-type="table" rid="T2">Table 2</xref>). Staghorn calculi were found in 50.6% patients.</p><table-wrap id="T2" orientation="portrait" position="anchor"><label>Table 2. </label><caption><title>Patient Characteristics (n=85).</title></caption><table frame="hsides" rules="groups" content-type="article-table"><thead><tr><th colspan="2" rowspan="1">Variable</th><th colspan="2" rowspan="1">Number (Percentages)</th></tr></thead><tbody><tr><td align="center" rowspan="2" colspan="1">Sex</td><td align="center" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">46 (54.1%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">39 (45.9%)</td></tr><tr><td align="center" rowspan="9" colspan="1">Symptoms</td><td align="center" rowspan="1" colspan="1">Renal colic</td><td align="center" rowspan="1" colspan="1">17 (20.2%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Flank pain</td><td align="center" rowspan="1" colspan="1">76 (89.3%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Passing stone</td><td align="center" rowspan="1" colspan="1">29 (34.5%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Sandy urination</td><td align="center" rowspan="1" colspan="1">10 (11.9%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Haematuria</td><td align="center" rowspan="1" colspan="1">18 (21.4%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Dysuria</td><td align="center" rowspan="1" colspan="1">3 (3.6%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Fever</td><td align="center" rowspan="1" colspan="1">4 (4.8%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Urinary retention</td><td align="center" rowspan="1" colspan="1">2 (2.4%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Intermittency</td><td align="center" rowspan="1" colspan="1">2 (2.4%)</td></tr><tr><td align="center" rowspan="2" colspan="1">Stone Side</td><td align="center" rowspan="1" colspan="1">Right</td><td align="center" rowspan="1" colspan="1">50 (59.0%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Left</td><td align="center" rowspan="1" colspan="1">35 (41.0%)</td></tr></tbody></table></table-wrap><p>The mean hematocrit drop was 5.20 &#x000b1; 3.36%. Average total blood loss was 560.92 &#x000b1; 428.43 mL with median 511.46 (95% CI: 0.00-1974.84) mL. There were two cases with pelvicalyceal laceration, one with massive hemorrhage (perioperative blood loss 1974.84 mL). There was no significant difference of total blood loss between the cases performed by the two PCNL surgeons (p&#x0003e;0.05).</p><p>Stepwise multivariate regression analysis which included variables with p-value &#x0003c; 0.25 (
<xref ref-type="table" rid="T3">Table 3</xref>) showed that stone burden was the most influential predictor of blood loss (p=0.037). Meanwhile operative time was found not associated (p-value &#x0003e;0.05) with blood loss. We assessed total blood loss (in mL) as -153.379 + 0.229 &#x000d7; stone burden (mm
<sup>2</sup>) + 0.203 &#x000d7; serum hematocrit baseline (%). This means it is predicted that a kidney stone patient with 1000 mm
<sup>2</sup> stone burden and baseline hematocrit 40% will have 83.74 mL blood loss during PCNL procedure perioperative.</p><table-wrap id="T3" orientation="portrait" position="anchor"><label>Table 3. </label><caption><title>Bivariate analysis between related factors and total blood loss.</title></caption><table frame="hsides" rules="groups" content-type="article-table"><thead><tr><th align="center" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">p-Value</th><th align="center" rowspan="1" colspan="1">R</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Stone burden**</td><td align="center" rowspan="1" colspan="1">0.067</td><td align="center" rowspan="1" colspan="1">0.200</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of stones**</td><td align="center" rowspan="1" colspan="1">0.380</td><td align="center" rowspan="1" colspan="1">0.096</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum creatinine baseline**</td><td align="center" rowspan="1" colspan="1">0.549</td><td align="center" rowspan="1" colspan="1">0.066</td></tr><tr><td align="left" rowspan="1" colspan="1">Red blood cell count**</td><td align="center" rowspan="1" colspan="1">0.095</td><td align="center" rowspan="1" colspan="1">0.182</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum hematocrit baseline*</td><td align="center" rowspan="1" colspan="1">0.135</td><td align="center" rowspan="1" colspan="1">0.163</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum hemoglobin baseline**</td><td align="center" rowspan="1" colspan="1">0.501</td><td align="center" rowspan="1" colspan="1">0.074</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index**</td><td align="center" rowspan="1" colspan="1">0.298</td><td align="center" rowspan="1" colspan="1">0.114</td></tr><tr><td align="left" rowspan="1" colspan="1">Age*</td><td align="center" rowspan="1" colspan="1">0.670</td><td align="center" rowspan="1" colspan="1">0.047</td></tr></tbody></table><table-wrap-foot><fn id="fn2"><p>*Pearson analysis **Spearman analysis</p></fn></table-wrap-foot></table-wrap><p>The average amount of blood units 435.29 &#x000b1; 114.13 mL was cross-matched for each procedure pre-operatively (
<xref ref-type="table" rid="T4">Table 4</xref>). Nevertheless, 87.1% of patients did not receive blood transfusion perioperatively, thus yielding the blood transfusion rate as 12.9%. Blood transfusion was required by 3.5% patients intra-operatively, 7.1% post-operatively and 2.3% both intra and post-operatively. In total, the cross-matched transfusion ratio was 7.72. The average amount of blood transfused during PCNL procedure: 356.00 &#x000b1; 145.88 mL.</p><table-wrap id="T4" orientation="portrait" position="anchor"><label>Table 4. </label><caption><title>Blood transfusion pattern.</title></caption><table frame="hsides" rules="groups" content-type="article-table"><thead><tr><th align="center" colspan="2" valign="top" rowspan="1">Blood Transfusion
<break/>Proportion (%)</th><th align="center" rowspan="1" colspan="1">Average amount of
<break/>blood unit cross-
<break/>matched</th><th align="center" rowspan="1" colspan="1">Average amount of blood
<break/>transfused (Intra-op &#x02013; 72-hour
<break/>post-op)</th><th align="center" valign="top" rowspan="1" colspan="1">&#x0003e;Under-
<break/>transfusion (%)</th><th align="center" valign="top" rowspan="1" colspan="1">&#x0003e;Over-
<break/>transfusion(%)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">No transfusion</td><td align="center" rowspan="1" colspan="1">87.1%</td><td align="center" rowspan="1" colspan="1">435.29 &#x000b1; 114.13 mL</td><td align="center" rowspan="1" colspan="1">356.00 &#x000b1; 145.88 mL</td><td align="center" rowspan="4" colspan="1">0%</td><td align="center" rowspan="4" colspan="1">100%</td></tr><tr><td align="center" rowspan="1" colspan="1">Intra-operative
<break/>transfusion</td><td align="center" rowspan="1" colspan="1">3.5%</td><td align="center" colspan="2" rowspan="1">
<italic><bold>Cross Match Transfusion Ratio</bold></italic>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Post-operative
<break/>transfusion</td><td align="center" rowspan="1" colspan="1">7.1%</td><td align="center" colspan="2" rowspan="2">7.72</td></tr><tr><td align="center" rowspan="1" colspan="1">Both intra &#x00026;
<break/>post-operative
<break/>transfusion</td><td align="center" rowspan="1" colspan="1">2.3%</td></tr></tbody></table></table-wrap><supplementary-material content-type="local-data" id="DS0"><label>Raw data for Table 3 of 'Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones'</label><caption><p>The raw data of the bivariate analysis between related factors and total blood loss are provided.</p></caption><media xlink:href="f1000research-5-9674-s0000.tgz"><caption><p>Click here for additional data file.</p></caption></media><permissions><copyright-statement>Copyright: &#x000a9; 2016 Syahputra FA et al.</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).</license-p></license></permissions></supplementary-material><supplementary-material content-type="local-data" id="DS1"><label>Raw data for Table 4 of 'Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones'</label><caption><p>The raw data for &#x02018;Blood transfusion practice&#x02019; are provided.</p></caption><media xlink:href="f1000research-5-9674-s0001.tgz"><caption><p>Click here for additional data file.</p></caption></media><permissions><copyright-statement>Copyright: &#x000a9; 2016 Syahputra FA et al.</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).</license-p></license></permissions></supplementary-material></sec><sec sec-type="discussion"><title>Discussion</title><p>In this study we did not use conventional, visual estimated blood loss to determine hemorrhage due to high bias factors, subjectivity, persistence of dilution effect and poor accuracy
<sup><xref rid="ref-19" ref-type="bibr">19</xref>&#x02013;
<xref rid="ref-23" ref-type="bibr">23</xref></sup>. Laboratory parameters in our study were recorded until 72-hours post-operatively, in order to minimize intravenous hydration and retroperitoneal fluid absorption effects. We used the hematocrit level as the main parameter to determine blood loss rather than hemoglobin to avoid hemodilution effect
<sup><xref rid="ref-15" ref-type="bibr">15</xref>,
<xref rid="ref-24" ref-type="bibr">24</xref></sup>; Furthermore, the hematocrit level positively correlated with the total blood volume
<sup><xref rid="ref-25" ref-type="bibr">25</xref></sup>. It has been reported that also a center in Turkey applies a blood transfusion policy that depends on the hematocrit level (transfusion was indicated when hematocrit level was less than 30%)
<sup><xref rid="ref-14" ref-type="bibr">14</xref></sup>.
</p><p>Stone burden was the most influential predictive factor for blood loss during the PCNL procedure in this study, similar to other studies performed. A multivariate analysis showed that complete and partial staghorn calculi were associated with a greater blood loss than with the calyx stones
<sup><xref rid="ref-14" ref-type="bibr">14</xref></sup>. Other studies concluded that larger stone burdens
<sup><xref rid="ref-11" ref-type="bibr">11</xref></sup> or staghorn calculi
<sup><xref rid="ref-26" ref-type="bibr">26</xref></sup> required a greater amount of unit blood transfused during the PCNL procedure compared to the smaller stones. Greater hematocrit level changes in staghorn calculi were found during PCNL, while further multivariate tests concluded that staghorn calculi were associated with a greater amount of blood loss (OR 1.92) and a greater decrease in the hemoglobin level compared to non-staghorn cases
<sup><xref rid="ref-13" ref-type="bibr">13</xref></sup>. Prolonged and excessive intra-renal maneuver performed for large stone burdens was assumed to increase incidence of injury to renal vasculature
<sup><xref rid="ref-11" ref-type="bibr">11</xref></sup>.
</p><p>Our transfusion rate was similar to the one reported in a retrospective study from Pakistan showing an overall blood transfusion rate of 14.2% with one angioembolization performed to control hemorrhage
<sup><xref rid="ref-26" ref-type="bibr">26</xref></sup>. In our study, all cases presenting with massive hemorrhage could be managed conservatively. Lower blood transfusion rates were reported in two other studies from Pakistan, one study from United Kingdom and one study from the United States; these differences occurred due to the younger age group
<sup><xref rid="ref-27" ref-type="bibr">27</xref></sup>, supine position used
<sup><xref rid="ref-28" ref-type="bibr">28</xref></sup> and balloon dilatation
<sup><xref rid="ref-29" ref-type="bibr">29</xref>,
<xref rid="ref-30" ref-type="bibr">30</xref></sup>. A higher transfusion rate (23.8%) compared to our result was shown in a retrospective analysis. An aggressive approach by torqueing the rigid nephroscope to maximize stone clearance at one stage was explained
<sup><xref rid="ref-14" ref-type="bibr">14</xref></sup>.
</p><p>A precise estimation of surgical blood loss is essential in order to avoid excessive usage of blood units. Most of the previous studies emphasize the estimated blood loss rather than the objective prediction. Our calculation of total blood loss included perioperative factors: the patient&#x02019;s blood volume (based on sex, body weight and height), the number of red cell units transfused, the hematocrit changes, and the amount of hemodilution. To our knowledge, this is the first study that has applied a mathematical approach to predict blood loss during PCNL procedures. We did not include hydronephrosis grading, parenchymal thickness and stone composition to analyze the predictive factors of blood loss, due to the possible limitations relating to our study.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Stone burden was the most influential PCNL blood loss predictive factor in our institution. We estimated that the amount of blood requested and cross-matched for PCNL is much greater than the actual blood loss. Our principle was proposed as a guidance to reduce any unnecessary costs and excessive requirements of blood units.</p></sec><sec><title>Consent</title><p>Written informed consent to participate in the study and publish clinical data was obtained by the patients.</p></sec><sec><title>Data availability</title><p>The data referenced by this article are under copyright with the following copyright statement: Copyright: &#x000a9; 2016 Syahputra FA et al.</p><p>Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"/>
</p><p>F1000Research: Dataset 1. Raw data for
<xref ref-type="table" rid="T3">Table 3</xref> of 'Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones',
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5256/f1000research.8993.d127629">10.5256/f1000research.8993.d127629</ext-link>
<sup><xref rid="ref-31" ref-type="bibr">31</xref></sup>
</p><p>F1000Research: Dataset 2. Raw data for
<xref ref-type="table" rid="T4">Table 4</xref> of 'Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones',
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5256/f1000research.8993.d127630">10.5256/f1000research.8993.d127630</ext-link>
<sup><xref rid="ref-32" ref-type="bibr">32</xref></sup>
</p></sec></body><back><ref-list><ref id="ref-1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saigal</surname><given-names>CS</given-names></name><name><surname>Joyce</surname><given-names>G</given-names></name><name><surname>Timilsina</surname><given-names>AR</given-names></name><etal/></person-group>:
<article-title>Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?</article-title>
<source><italic>Kidney Int.</italic></source>
<year>2005</year>;<volume>68</volume>(<issue>4</issue>):<fpage>1808</fpage>&#x02013;<lpage>14</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1523-1755.2005.00599.x</pub-id>
<pub-id pub-id-type="pmid">16164658</pub-id></mixed-citation></ref><ref id="ref-2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hesse</surname><given-names>A</given-names></name><name><surname>Br&#x000e4;ndle</surname><given-names>E</given-names></name><name><surname>Wilbert</surname><given-names>D</given-names></name><etal/></person-group>:
<article-title>Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.</article-title>
<source><italic>Eur Urol.</italic></source>
<year>2003</year>;<volume>44</volume>(<issue>6</issue>):<fpage>709</fpage>&#x02013;<lpage>13</lpage>.
<pub-id pub-id-type="doi">10.1016/S0302-2838(03)00415-9</pub-id>
<pub-id pub-id-type="pmid">14644124</pub-id></mixed-citation></ref><ref id="ref-3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yasui</surname><given-names>T</given-names></name><name><surname>Iguchi</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><etal/></person-group>:
<article-title>Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005.</article-title>
<source><italic>Urology.</italic></source>
<year>2008</year>;<volume>71</volume>(<issue>2</issue>):<fpage>209</fpage>&#x02013;<lpage>13</lpage>.
<pub-id pub-id-type="doi">10.1016/j.urology.2007.09.034</pub-id>
<pub-id pub-id-type="pmid">18308085</pub-id></mixed-citation></ref><ref id="ref-4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Romero</surname><given-names>V</given-names></name><name><surname>Akpinar</surname><given-names>H</given-names></name><name><surname>Assimos</surname><given-names>DG</given-names></name></person-group>:
<article-title>Kidney stones: a global picture of prevalence, incidence, and associated risk factors.</article-title>
<source><italic>Rev Urol.</italic></source>
<year>2010</year>;<volume>12</volume>(<issue>2&#x02013;3</issue>):<fpage>e86</fpage>&#x02013;<lpage>96</lpage>.
<!--<pub-id pub-id-type="pmcid">2931286</pub-id>-->
<pub-id pub-id-type="pmid">20811557</pub-id></mixed-citation></ref><ref id="ref-5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahardjo</surname><given-names>D</given-names></name></person-group>:
<article-title>Perkembangan penatalaksanaan batu ginjal di RSCM tahun 1997&#x02013;2002.</article-title>
<source><italic>J I Bedah Indones.</italic></source>
<year>2004</year>;<volume>32</volume>:<fpage>58</fpage>&#x02013;<lpage>63</lpage>.</mixed-citation></ref><ref id="ref-6"><label>6</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Ost</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>Percutaneous management of the upper urinary tract</article-title>. In Wein A, Novick A and Peters C:
<italic>Campbell's urology.</italic>Philadelphia, W.B. Saunders Co,<year>2007</year>;<fpage>1526</fpage>&#x02013;<lpage>1563</lpage>.</mixed-citation></ref><ref id="ref-7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Skolarikos</surname><given-names>A</given-names></name><name><surname>Alivizatos</surname><given-names>G</given-names></name><name><surname>de la Rosette</surname><given-names>JJ</given-names></name></person-group>:
<article-title>Percutaneous nephrolithotomy and its legacy.</article-title>
<source><italic>Eur Urol.</italic></source>
<year>2005</year>;<volume>47</volume>(<issue>1</issue>):<fpage>22</fpage>&#x02013;<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.eururo.2004.08.009</pub-id>
<pub-id pub-id-type="pmid">15582245</pub-id></mixed-citation></ref><ref id="ref-8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>T&#x000fc;rk</surname><given-names>C</given-names></name><name><surname>Knoll</surname><given-names>T</given-names></name><name><surname>Petrik</surname><given-names>A</given-names></name><etal/></person-group>:
<article-title>Guidelines on Urolithiasis.</article-title>
<year>2013</year>;<volume>5</volume>:<fpage>19</fpage>&#x02013;<lpage>40</lpage>.
<ext-link ext-link-type="uri" xlink:href="https://uroweb.org/wp-content/uploads/22-Urolithiasis_LR1.pdf">Reference Source</ext-link>
</mixed-citation></ref><ref id="ref-9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Preminger</surname><given-names>GM</given-names></name><name><surname>Assimos</surname><given-names>DG</given-names></name><name><surname>Lingeman</surname><given-names>JE</given-names></name><etal/></person-group>:
<article-title>Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations.</article-title>
<source><italic>J Urol.</italic></source>
<year>2005</year>;<volume>173</volume>(<issue>6</issue>):<fpage>1991</fpage>&#x02013;<lpage>2000</lpage>.
<pub-id pub-id-type="doi">10.1097/01.ju.0000161171.67806.2a</pub-id>
<pub-id pub-id-type="pmid">15879803</pub-id></mixed-citation></ref><ref id="ref-10"><label>10</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Birowo</surname><given-names>P</given-names></name><name><surname>Rasyid</surname><given-names>N</given-names></name></person-group>:
<article-title>Sekilas perjalanan hidup dr. Rochani, Sp.B, Sp.U(K)</article-title>. In Birowo P:
<italic>Purna bakti dr. Rochani, Sp.B, Sp.U(K).</italic>Jakarta, Divisi Urologi Departemen Ilmu Bedah FKUI/Departemen Urologi RSCM,<year>2010</year>.</mixed-citation></ref><ref id="ref-11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kukreja</surname><given-names>R</given-names></name><name><surname>Desai</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><etal/></person-group>:
<article-title>Factors affecting blood loss during percutaneous nephrolithotomy: prospective study.</article-title>
<source><italic>J Endourol.</italic></source>
<year>2004</year>;<volume>18</volume>(<issue>8</issue>):<fpage>715</fpage>&#x02013;<lpage>22</lpage>.
<pub-id pub-id-type="doi">10.1089/end.2004.18.715</pub-id>
<pub-id pub-id-type="pmid">15659890</pub-id></mixed-citation></ref><ref id="ref-12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keoghane</surname><given-names>SR</given-names></name><name><surname>Cetti</surname><given-names>RJ</given-names></name><name><surname>Rogers</surname><given-names>AE</given-names></name><etal/></person-group>:
<article-title>Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL).</article-title>
<source><italic>BJU Int.</italic></source>
<year>2013</year>;<volume>111</volume>(<issue>4</issue>):<fpage>628</fpage>&#x02013;<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1464-410X.2012.11394.x</pub-id>
<pub-id pub-id-type="pmid">22958458</pub-id></mixed-citation></ref><ref id="ref-13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Akman</surname><given-names>T</given-names></name><name><surname>Binbay</surname><given-names>M</given-names></name><name><surname>Sari</surname><given-names>E</given-names></name><etal/></person-group>:
<article-title>Factors affecting bleeding during percutaneous nephrolithotomy: single surgeon experience.</article-title>
<source><italic>J Endourol.</italic></source>
<year>2011</year>;<volume>25</volume>(<issue>2</issue>):<fpage>327</fpage>&#x02013;<lpage>33</lpage>.
<pub-id pub-id-type="doi">10.1089/end.2010.0302</pub-id>
<pub-id pub-id-type="pmid">21214412</pub-id></mixed-citation></ref><ref id="ref-14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turna</surname><given-names>B</given-names></name><name><surname>Nazli</surname><given-names>O</given-names></name><name><surname>Demiryoguran</surname><given-names>S</given-names></name><etal/></person-group>:
<article-title>Percutaneous nephrolithotomy: variables that influence hemorrhage.</article-title>
<source><italic>Urology.</italic></source>
<year>2007</year>;<volume>69</volume>(<issue>4</issue>):<fpage>603</fpage>&#x02013;<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.urology.2006.12.021</pub-id>
<pub-id pub-id-type="pmid">17445632</pub-id></mixed-citation></ref><ref id="ref-15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosencher</surname><given-names>N</given-names></name><name><surname>Kerkkamp</surname><given-names>HE</given-names></name><name><surname>Macheras</surname><given-names>G</given-names></name><etal/></person-group>:
<article-title>Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe.</article-title>
<source><italic>Transfusion.</italic></source>
<year>2003</year>;<volume>43</volume>(<issue>4</issue>):<fpage>459</fpage>&#x02013;<lpage>69</lpage>.
<pub-id pub-id-type="doi">10.1046/j.1537-2995.2003.00348.x</pub-id>
<pub-id pub-id-type="pmid">12662278</pub-id></mixed-citation></ref><ref id="ref-16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hurle</surname><given-names>R</given-names></name><name><surname>Poma</surname><given-names>R</given-names></name><name><surname>Maffezzini</surname><given-names>M</given-names></name><etal/></person-group>:
<article-title>A simple mathematical approach to calculate blood loss in radical prostatectomy.</article-title>
<source><italic>Urol Int.</italic></source>
<year>2004</year>;<volume>72</volume>(<issue>2</issue>):<fpage>135</fpage>&#x02013;<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1159/000075967</pub-id>
<pub-id pub-id-type="pmid">14963354</pub-id></mixed-citation></ref><ref id="ref-17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khan</surname><given-names>FA</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Ali</surname><given-names>A</given-names></name><etal/></person-group>:
<article-title>Estimation of blood loss during Caesarean section: an audit.</article-title>
<source><italic>J Pak Med Assoc.</italic></source>
<year>2006</year>;<volume>56</volume>(<issue>12</issue>):<fpage>572</fpage>&#x02013;<lpage>5</lpage>.
<pub-id pub-id-type="pmid">17312645</pub-id></mixed-citation></ref><ref id="ref-18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seruya</surname><given-names>M</given-names></name><name><surname>Oh</surname><given-names>AK</given-names></name><name><surname>Rogers</surname><given-names>GF</given-names></name><etal/></person-group>:
<article-title>Blood loss estimation during fronto-orbital advancement: implications for blood transfusion practice and hospital length of stay.</article-title>
<source><italic>J Craniofac Surg.</italic></source>
<year>2012</year>;<volume>23</volume>(<issue>5</issue>):<fpage>1314</fpage>&#x02013;<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1097/SCS.0b013e31825bd02a</pub-id>
<pub-id pub-id-type="pmid">22976629</pub-id></mixed-citation></ref><ref id="ref-19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poletajew</surname><given-names>S</given-names></name><name><surname>Antoniewicz</surname><given-names>AA</given-names></name></person-group>:
<article-title>Blood loss during laparoscopic radical prostatectomy - is it significant or not?</article-title>
<source><italic>Cent European J Urol.</italic></source>
<year>2012</year>;<volume>65</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02013;<lpage>13</lpage>.
<pub-id pub-id-type="doi">10.5173/ceju.2012.01.art3</pub-id>
<pub-id pub-id-type="pmid">24578914</pub-id></mixed-citation></ref><ref id="ref-20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McCullough</surname><given-names>TC</given-names></name><name><surname>Roth</surname><given-names>JV</given-names></name><name><surname>Ginsberg</surname><given-names>PC</given-names></name><etal/></person-group>:
<article-title>Estimated blood loss underestimates calculated blood loss during radical retropubic prostatectomy.</article-title>
<source><italic>Urol Int.</italic></source>
<year>2004</year>;<volume>72</volume>(<issue>1</issue>):<fpage>13</fpage>&#x02013;<lpage>16</lpage>.
<pub-id pub-id-type="doi">10.1159/000075266</pub-id>
<pub-id pub-id-type="pmid">14730159</pub-id></mixed-citation></ref><ref id="ref-21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stafford</surname><given-names>I</given-names></name><name><surname>Dildy</surname><given-names>GA</given-names></name><name><surname>Clark</surname><given-names>SL</given-names></name><etal/></person-group>:
<article-title>Visually estimated and calculated blood loss in vaginal and cesarean delivery.</article-title>
<source><italic>Am J Obstet Gynecol.</italic></source>
<year>2008</year>;<volume>199</volume>(<issue>5</issue>):<fpage>519.e1</fpage>&#x02013;<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ajog.2008.04.049</pub-id>
<pub-id pub-id-type="pmid">18639209</pub-id></mixed-citation></ref><ref id="ref-22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gharoro</surname><given-names>EP</given-names></name><name><surname>Enabudoso</surname><given-names>EJ</given-names></name></person-group>:
<article-title>Relationship between visually estimated blood loss at delivery and postpartum change in haematocrit.</article-title>
<source><italic>J Obstet Gynaecol.</italic></source>
<year>2009</year>;<volume>29</volume>(<issue>6</issue>):<fpage>517</fpage>&#x02013;<lpage>520</lpage>.
<pub-id pub-id-type="doi">10.1080/01443610903003159</pub-id>
<pub-id pub-id-type="pmid">19697200</pub-id></mixed-citation></ref><ref id="ref-23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schorn</surname><given-names>MN</given-names></name></person-group>:
<article-title>Measurement of blood loss: review of the literature.</article-title>
<source><italic>J Midwifery Womens Health.</italic></source>
<year>2010</year>;<volume>55</volume>(<issue>1</issue>):<fpage>20</fpage>&#x02013;<lpage>27</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jmwh.2009.02.014</pub-id>
<pub-id pub-id-type="pmid">20129226</pub-id></mixed-citation></ref><ref id="ref-24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kukreja</surname><given-names>R</given-names></name><name><surname>Desai</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><etal/></person-group>:
<article-title>Factors affecting blood loss during percutaneous nephrolithotomy: prospective study.</article-title>
<source><italic>J Endourol.</italic></source>
<year>2004</year>;<volume>18</volume>(<issue>8</issue>):<fpage>715</fpage>&#x02013;<lpage>722</lpage>.
<pub-id pub-id-type="doi">10.1089/end.2004.18.715</pub-id>
<pub-id pub-id-type="pmid">15659890</pub-id></mixed-citation></ref><ref id="ref-25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turna</surname><given-names>B</given-names></name><name><surname>Nazli</surname><given-names>O</given-names></name><name><surname>Demiryoguran</surname><given-names>S</given-names></name><etal/></person-group>:
<article-title>Percutaneous nephrolithotomy: variables that influence hemorrhage.</article-title>
<source><italic>Urology.</italic></source>
<year>2007</year>;<volume>69</volume>(<issue>4</issue>):<fpage>603</fpage>&#x02013;<lpage>607</lpage>.
<pub-id pub-id-type="doi">10.1016/j.urology.2006.12.021</pub-id>
<pub-id pub-id-type="pmid">17445632</pub-id></mixed-citation></ref><ref id="ref-26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zehri</surname><given-names>AA</given-names></name><name><surname>Biyabani</surname><given-names>SR</given-names></name><name><surname>Siddiqui</surname><given-names>KM</given-names></name><etal/></person-group>:
<article-title>Triggers of blood transfusion in percutaneous nephrolithotomy.</article-title>
<source><italic>J Coll Physicians Surg Pak.</italic></source>
<year>2011</year>;<volume>21</volume>(<issue>3</issue>):<fpage>138</fpage>&#x02013;<lpage>41</lpage>.
<pub-id pub-id-type="pmid">21419018</pub-id></mixed-citation></ref><ref id="ref-27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mahmud</surname><given-names>M</given-names></name><name><surname>Zaidi</surname><given-names>Z</given-names></name></person-group>:
<article-title>Percutaneous nephrolithotomy in children before school age: experience of a Pakistani centre.</article-title>
<source><italic>BJU Int.</italic></source>
<year>2004</year>;<volume>94</volume>(<issue>9</issue>):<fpage>1352</fpage>&#x02013;<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1464-410X.2004.05173.x</pub-id>
<pub-id pub-id-type="pmid">15610120</pub-id></mixed-citation></ref><ref id="ref-28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rana</surname><given-names>AM</given-names></name><name><surname>Bhojwani</surname><given-names>JP</given-names></name><name><surname>Junejo</surname><given-names>NN</given-names></name><etal/></person-group>:
<article-title>Tubeless PCNL with patient in supine position: procedure for all seasons?--with comprehensive technique.</article-title>
<source><italic>Urology.</italic></source>
<year>2008</year>;<volume>71</volume>(<issue>4</issue>):<fpage>581</fpage>&#x02013;<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1016/j.urology.2007.10.059</pub-id>
<pub-id pub-id-type="pmid">18279935</pub-id></mixed-citation></ref><ref id="ref-29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Armitage</surname><given-names>JN</given-names></name><name><surname>Irving</surname><given-names>SO</given-names></name><name><surname>Burgess</surname><given-names>NA</given-names></name><etal/></person-group>:
<article-title>Percutaneous nephrolithotomy in the United kingdom: results of a prospective data registry.</article-title>
<source><italic>Eur Urol.</italic></source>
<year>2012</year>;<volume>61</volume>(<issue>6</issue>):<fpage>1188</fpage>&#x02013;<lpage>93</lpage>.
<pub-id pub-id-type="doi">10.1016/j.eururo.2012.01.003</pub-id>
<pub-id pub-id-type="pmid">22244778</pub-id></mixed-citation></ref><ref id="ref-30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tomaszewski</surname><given-names>JJ</given-names></name><name><surname>Smaldone</surname><given-names>MC</given-names></name><name><surname>Schuster</surname><given-names>T</given-names></name><etal/></person-group>:
<article-title>Factors affecting blood loss during percutaneous nephrolithotomy using balloon dilation in a large contemporary series.</article-title>
<source><italic>J Endourol.</italic></source>
<year>2010</year>;<volume>24</volume>(<issue>2</issue>):<fpage>207</fpage>&#x02013;<lpage>11</lpage>.
<pub-id pub-id-type="doi">10.1089/end.2009.0402</pub-id>
<pub-id pub-id-type="pmid">20039798</pub-id></mixed-citation></ref><ref id="ref-31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Syahputra</surname><given-names>FA</given-names></name><name><surname>Birowo</surname><given-names>P</given-names></name><name><surname>Rasyid</surname><given-names>N</given-names></name><etal/></person-group>:
<article-title>Dataset 1 in: Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones: a prospective study.</article-title>
<source><italic>F1000Research.</italic></source>
<year>2016</year>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5256/f1000research.8993.d127629">Data Source</ext-link>
</mixed-citation></ref><ref id="ref-32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Syahputra</surname><given-names>FA</given-names></name><name><surname>Birowo</surname><given-names>P</given-names></name><name><surname>Rasyid</surname><given-names>N</given-names></name><etal/></person-group>:
<article-title>Dataset 2 in: Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones: a prospective study.</article-title>
<source><italic>F1000Research.</italic></source>
<year>2016</year>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5256/f1000research.8993.d127630">Data Source</ext-link>
</mixed-citation></ref></ref-list></back><sub-article id="report14725" article-type="peer-review"><front-stub><article-id pub-id-type="doi">10.5256/f1000research.9674.r14725</article-id><title-group><article-title>Referee response for version 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Soebadi</surname><given-names>Doddy Musbadianto</given-names></name><xref ref-type="aff" rid="r14725a1">1</xref><role>Referee</role></contrib><aff id="r14725a1">
<label>1</label>Department of Urology, Airlangga University, Surabaya, Indonesia</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>7</month><year>2016</year></pub-date><related-article id="d35e2524" related-article-type="peer-reviewed-article" ext-link-type="doi" xlink:href="10.12688/f1000research.8993.1">Version 1</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve</meta-value></custom-meta></custom-meta-group></front-stub><body><p>This is a nice article concerning blood loss during percutaneous nephrolithotomy&#x000a0;(PCNL) procedures. We need these data to confirm that this procedure is safe to be done in a proper way.</p><p> The authors have meticulously analyzed and discussed the results.</p><p>I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p></body></sub-article><sub-article id="report14722" article-type="peer-review"><front-stub><article-id pub-id-type="doi">10.5256/f1000research.9674.r14722</article-id><title-group><article-title>Referee response for version 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Usawachintachit</surname><given-names>Manint</given-names></name><xref ref-type="aff" rid="r14722a1">1</xref><xref ref-type="aff" rid="r14722a2">2</xref><role>Referee</role></contrib><aff id="r14722a1">
<label>1</label>Department of Urology, University of California San Francisco, San Francisco, CA, USA</aff><aff id="r14722a2">
<label>2</label>Division of Urology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>11</day><month>7</month><year>2016</year></pub-date><related-article id="d35e2584" related-article-type="peer-reviewed-article" ext-link-type="doi" xlink:href="10.12688/f1000research.8993.1">Version 1</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve-with-reservations</meta-value></custom-meta></custom-meta-group></front-stub><body><p>The authors present a study looking for predictive factor of blood loss following PCNL from a single institution for 85 patients over a 1-year period. It&#x02019;s interesting data in that while most relevant published studies were carried out retrospectively, this study is prospective. The primary endpoints were changes in hematocrit level and blood transfusion requirement over an early postoperative period. &#x000a0;&#x000a0;</p><p> Overall, the paper was written concisely with a good methodology to track blood loss level. I would recommend some revision enumerated below: &#x000a0;</p><p>
<bold>General comments</bold>
<list list-type="bullet"><list-item><p>Besides grammatical errors, there are some misspelled words.</p></list-item></list> &#x000a0;</p><p>
<bold>Abstract</bold>
<list list-type="bullet"><list-item><p>In the Result, a percentage of intra and postoperative transfusion should be 2.3%, not 23%.</p></list-item><list-item><p>It may be helpful to add a conclusion to&#x000a0;the abstract. &#x000a0;</p></list-item></list> &#x000a0;</p><p>
<bold>Introduction</bold>
<list list-type="bullet"><list-item><p>No specific comments.</p></list-item></list> &#x000a0;</p><p>
<bold>Material and Methods</bold>
<list list-type="bullet"><list-item><p>Were all patients included in this study consecutively?</p></list-item><list-item><p>How was stone burden assessed by means of imaging? Was it measured from CT-scan, plain film, or IVP?</p></list-item><list-item><p>How was a hematocrit level measured? Was it from a full blood draw or just fingertip needle sticks crude measurement? &#x000a0;</p></list-item><list-item><p>What was an algorithm of decision for perioperative blood transfusion in this study? Did the authors make a judgement based on a &#x0201c;specific&#x0201d; cutoff point of the most recent blood count (at 12, 24, 36, and 72 hours after PCNL) or make a decision subjectively? There should be a systematic methodology in this issue because it significantly affected transfusion rate and volume. &#x000a0;&#x000a0;&#x000a0;</p></list-item></list> &#x000a0;</p><p>
<bold>Results</bold>
<list list-type="bullet"><list-item><p>How many patients were excluded from this study because of a conversion to open procedure? Were they converted from profound intraoperative bleeding?</p></list-item><list-item><p>What were a mean BMI of patients, and distribution of hydronephrosis in this series? The authors have mentioned in the Introduction that they were risk factors for blood transfusion flowing PCNL.</p></list-item><list-item><p>What was a distribution of renal access (upper/middle/lower/multi-tract) in this study? Did number of renal access tract affect blood loss or transfusion rate?</p></list-item><list-item><p>In a multivariate analysis of variables and blood loss, was stone burden (p = 0.037) the only one factor that remained statistically significant? This data was not shown in Table 3. What were other variables included in the multivariate analysis and why did the authors include operative time (p &#x0003e; 0.05) in this model? &#x000a0;&#x000a0;</p></list-item></list> &#x000a0;</p><p>
<bold>Discussion</bold>
<list list-type="bullet"><list-item><p>The authors mentioned a hematocrit cut-point of 30% from a Turkish study. Did the authors use the same cut-point for transfusion in this study?</p></list-item><list-item><p>Transfusion rate in this series was relatively high (12.9%) and the authors have demonstrated a significant correlation between stone burden and blood loss. Could this high transfusion rate cause by a larger stone burden? This data (mean stone burden) was not shown in the manuscript.</p></list-item><list-item><p>What is a clinical benefit of the mathematical equation to predict blood loss preoperatively? Could we use it to obviate blood request in some patients?</p></list-item></list> &#x000a0;</p><p>
<bold>Miscellaneous</bold>
<list list-type="bullet"><list-item><p>In Table 2, it may be more understandable to order presenting symptoms by percentages.</p></list-item><list-item><p>In Dataset 1, why did the authors perform PCNL in some stones of 5 mm
<sup>2</sup> size. Is it more reasonable to treat them with ESWL or flexible ureteroscopy.&#x000a0;&#x000a0;</p></list-item></list>
</p><p>I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p></body></sub-article><sub-article id="report14721" article-type="peer-review"><front-stub><article-id pub-id-type="doi">10.5256/f1000research.9674.r14721</article-id><title-group><article-title>Referee response for version 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ather</surname><given-names>M Hammad</given-names></name><xref ref-type="aff" rid="r14721a1">1</xref><role>Referee</role></contrib><aff id="r14721a1">
<label>1</label>Section of Urology, Aga khan University, Karachi, Pakistan</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>6</month><year>2016</year></pub-date><related-article id="d35e2738" related-article-type="peer-reviewed-article" ext-link-type="doi" xlink:href="10.12688/f1000research.8993.1">Version 1</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve-with-reservations</meta-value></custom-meta></custom-meta-group></front-stub><body><p>Authors have assessed the predictive value of various parameters for transfusion during / following PCNL. It is an important area as bleeding and need for transfusion is still a major concern during PCNL. I read with interest the fact that the authors have performed all procedures under spinal anesthesia. Although it is feasible and has been reported in literature it is both cumbersome for patients, anesthetist and surgeon to perform this procedure in an awake patient. In addition to maintain level of spinal anesthesia to provide pain free procedure and yet not compromising ventilation in a spontaneously breathing patient is a difficult task. It is not clear from the methods described if the procedure was performed in prone or supine position. In the methods section authors have noted that "the procedure was randomly performed.....", I am not sure as to what the authors intended to mean. In addition in the methods section authors have noted that the "The procedure was completed when the patient was stone-free and any arising complications alleviated. " the meaning of this sentence is also not clear. In the results section authors have noted that "statistical power of 0.8 ", kindly clarify the sentence.</p><p> Authors noted stone burden as clinical (statistically significant) factor in predicting need for transfusion. This is conformed by many previous studies and authors conclusion does not surprise me.</p><p> In recent years many scoring systems have been developed to predict complexity of the procedure and stone free rate like STONE nephrolithomeetry score, Guys score etc. Authors should comment why they decided to use stone burden rather than these scores in predicting complexity level of the procedure and predicting need for transfusion.</p><p> A recent report by Un
<italic>et al.,</italic>&#x000a0;2015
<sup><xref rid="rep-ref-14721-1" ref-type="bibr">1</xref></sup>&#x000a0;noted transfusion requirement of ~10% and need for embolization in &#x0003c;1% in over 1400 PCNL over a 7 years period.</p><p>I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p></body><back><ref-list><title>References</title><ref id="rep-ref-14721-1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Un</surname><given-names>S</given-names></name><name><surname>Cakir</surname><given-names>V</given-names></name><name><surname>Kara</surname><given-names>C</given-names></name><name><surname>Turk</surname><given-names>H</given-names></name><name><surname>Kose</surname><given-names>O</given-names></name><name><surname>Balli</surname><given-names>O</given-names></name><name><surname>Yilmaz</surname><given-names>Y</given-names></name></person-group>:
<article-title>Risk factors for hemorrhage requiring embolization after percutaneous nephrolithotomy.</article-title>
<source><italic>Can Urol Assoc J</italic></source>.<volume>9</volume>(<issue>9-10</issue>) :
<elocation-id>10.5489/cuaj.2803</elocation-id>
<fpage>E594</fpage>-<lpage>8</lpage>
<pub-id pub-id-type="doi">10.5489/cuaj.2803</pub-id>
<pub-id pub-id-type="pmid">26425220</pub-id></mixed-citation></ref></ref-list></back></sub-article></article>